Your browser doesn't support javascript.
loading
Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression.
LaCasse, Rachel A; Striebel, James F; Favara, Cynthia; Kercher, Lisa; Chesebro, Bruce.
Affiliation
  • LaCasse RA; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, United States.
J Neuroimmunol ; 196(1-2): 16-26, 2008 May 30.
Article in En | MEDLINE | ID: mdl-18396336
ABSTRACT
Prion diseases are neurodegenerative infections with gliosis and vacuolation. The mechanisms of degeneration remain unclear, but chemokines may be important. In current experiments CCR1 knock-out (KO) mice succumbed more rapidly to scrapie infection than WT controls. Infected KO mice had upregulation of CCL3, a CCR1 ligand, and CCR5, a receptor with specificity for CCL3. Both infected KO and WT mice had upregulation of CCR5-mediated signaling involving activation of Erk1/2 in astrocytes; however, activation was earlier in KO mice suggesting a role in pathogenesis. In both mouse strains activation of the Erk1/2 pathway may lead to astrocyte dysfunction resulting in neurodegeneration.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation / Prion Diseases / PrPSc Proteins / Mitogen-Activated Protein Kinase 3 / Receptors, CCR1 Type of study: Etiology_studies Limits: Animals Language: En Journal: J Neuroimmunol Year: 2008 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation / Prion Diseases / PrPSc Proteins / Mitogen-Activated Protein Kinase 3 / Receptors, CCR1 Type of study: Etiology_studies Limits: Animals Language: En Journal: J Neuroimmunol Year: 2008 Document type: Article Affiliation country: United States